posted on 2015-12-17, 01:33authored byRishi Sharma, Spyros P. Nikas, Jason Jianxin Guo, Srikrishnan Mallipeddi, JodiAnne
T. Wood, Alexandros Makriyannis
As a part of our controlled-deactivation
ligand development project,
we recently disclosed a series of (−)-Δ8-tetrahydrocannabinols
(THCs) with a metabolically labile ester group at the 2′-position
of the side chain. Now, we have replaced the C-ring in the classical
THC structure with a hydrolyzable seven-membered lactone. One of the
synthesized analogues binds with high affinity to the CB1 receptor
(Ki = 4.6 nM) and exhibits much lower
affinities for the mCB2 and the hCB2. Also, in vitro functional characterization
found the compound to be an agonist at rCB1. Consistent with our rational
design, the lead cannabinergic lactone identified here is susceptible
to metabolic inactivation by plasma esterases, while the respective
acid metabolite is inactive at CB receptors. These results are highlighted
with molecular modeling of the two regiosomeric lactones.